The Aroon Indicator for FHI entered a downward trend on August 28, 2023. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 124 similar instances where the Aroon Indicator formed such a pattern. In of the 124 cases the stock moved lower. This puts the odds of a downward move at .
The 10-day RSI Indicator for FHI moved out of overbought territory on September 05, 2023. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 similar instances where the indicator moved out of overbought territory. In of the 36 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Momentum Indicator moved below the 0 level on September 26, 2023. You may want to consider selling the stock, shorting the stock, or exploring put options on FHI as a result. In of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for FHI turned negative on September 25, 2023. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .
FHI moved below its 50-day moving average on September 26, 2023 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FHI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The 10-day moving average for FHI crossed bullishly above the 50-day moving average on September 01, 2023. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where FHI advanced for three days, in of 323 cases, the price rose further within the following month. The odds of a continued upward trend are .
FHI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.632) is normal, around the industry mean (3.481). P/E Ratio (11.261) is within average values for comparable stocks, (30.530). Projected Growth (PEG Ratio) (1.056) is also within normal values, averaging (4.606). Dividend Yield (0.032) settles around the average of (0.072) among similar stocks. P/S Ratio (1.824) is also within normal values, averaging (78.133).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock slightly better than average.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. FHI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a company, which engages in the provision of investment management products and related financial services
|ETFs / NAME||Price $||Chg $||Chg %|
|Xtrackers MSCI EAFE High Div Yld Eq ETF|
|RiverNorth Managed Duration Municipal Income Fund II|
|VanEck Lg/Flat Trend ETF|
|T. Rowe Price Dividend Growth ETF|
|Nuveen ESG High Yield Corporate Bd ETF|
A.I.dvisor indicates that over the last year, FHI has been loosely correlated with PFG. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if FHI jumps, then PFG could also see price increases.